|Bid||71.12 x 1000|
|Ask||71.74 x 44000|
|Day's Range||81.63 - 82.65|
|52 Week Range||66.72 - 92.97|
|PE Ratio (TTM)||11.32|
|Dividend & Yield||3.30 (3.39%)|
|1y Target Est||N/A|
Regeneron Pharmaceuticals has a slew of clinical trials going on, and studies evaluating REGN-2810 could be the most important.
Late last week, Biogen (BIIB) and six other pharma and biotech stocks were in the news due to the pricing of their multiple sclerosis ("MS") drugs.
Sanofi Pasteur, Sanofi’s (SNY) human vaccine business, reported 26.2% revenue growth at constant exchange rates to 1.0 billion euros in 2Q17. Sanofi Pasteur reported growth across all product franchises ...